Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergio Valente

Showing results (131-140 of 155) with videos related to

Pageof 16
Sort By:
Chemmedchem|March 28, 2017
Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone AcetyltransferaseValentina Noemi Madia, Rosaria Benedetti, Maria Letizia Barreca, et al.
Cell Chemical Biology|October 22, 2024
Quinoline-based compounds can inhibit diverse enzymes that act on DNAJujun Zhou, Qin Chen, Ren Ren, et al.
Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Oncotarget|October 6, 2017
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cellsEvelina Miele, Sergio Valente, Vincenzo Alfano, et al.
Chemmedchem|February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target ModulationRossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Journal of Medicinal Chemistry|December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activitiesDante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Journal of Medicinal Chemistry|July 13, 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer CellsClemens Zwergel, Michele Aventaggiato, Sabrina Garbo, et al.
Human Genetics|January 11, 2020
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 geneVeronica Nobile, Federica Palumbo, Stella Lanni, et al.
Cancer Research|February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Pageof 16

Showing results (131-140 of 155) with videos related to

Sort By:
Pageof 16
Chemmedchem|March 28, 2017
Structure-Activity Relationships on Cinnamoyl Derivatives as Inhibitors of p300 Histone AcetyltransferaseValentina Noemi Madia, Rosaria Benedetti, Maria Letizia Barreca, et al.
Cell Chemical Biology|October 22, 2024
Quinoline-based compounds can inhibit diverse enzymes that act on DNAJujun Zhou, Qin Chen, Ren Ren, et al.
Cancer Letters|September 3, 2025
TP53-agnostic lethality through combined pan-HDAC and CDK inhibition in acute myeloid leukemiaAurélien Pottier, Sujung Park, Yejin Lee, et al.
Cancers|February 21, 2020
Novel Quinoline Compounds Active in Cancer Cells through Coupled DNA Methyltransferase Inhibition and DegradationClemens Zwergel, Rossella Fioravanti, Giulia Stazi, et al.
Oncotarget|October 6, 2017
The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cellsEvelina Miele, Sergio Valente, Vincenzo Alfano, et al.
Chemmedchem|February 1, 2020
Tranylcypromine-Based LSD1 Inhibitors: Structure-Activity Relationships, Antiproliferative Effects in Leukemia, and Gene Target ModulationRossella Fioravanti, Annalisa Romanelli, Nicola Mautone, et al.
Journal of Medicinal Chemistry|December 12, 2013
Pan-histone demethylase inhibitors simultaneously targeting Jumonji C and lysine-specific demethylases display high anticancer activitiesDante Rotili, Stefano Tomassi, Mariarosaria Conte, et al.
Journal of Medicinal Chemistry|July 13, 2023
Novel 1,4-Dihydropyridines as Specific Binders and Activators of SIRT3 Impair Cell Viability and Clonogenicity and Downregulate Hypoxia-Induced Targets in Cancer CellsClemens Zwergel, Michele Aventaggiato, Sabrina Garbo, et al.
Human Genetics|January 11, 2020
Altered mitochondrial function in cells carrying a premutation or unmethylated full mutation of the FMR1 geneVeronica Nobile, Federica Palumbo, Stella Lanni, et al.
Cancer Research|February 26, 2014
Context-selective death of acute myeloid leukemia cells triggered by the novel hybrid retinoid-HDAC inhibitor MC2392Floriana De Bellis, Vincenzo Carafa, Mariarosaria Conte, et al.
Pageof 16